John Jacobsen
Nessuna posizione attualmente
Profilo
John Jacobsen worked as a Senior Director-Medicinal Chemistry at Theravance Biopharma, Inc. from 1998 to 2015.
He then worked as the Chief Scientific Officer at DiCE Therapeutics, Inc. from 2021 to 2023.
Prior to his career, he earned an undergraduate degree from Harvard College and a doctorate from the University of California, Berkeley.
Precedenti posizioni note di John Jacobsen
| Società | Posizione | Fine |
|---|---|---|
| DICE THER | Chief Tech/Sci/R&D Officer | 09/08/2023 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/10/2015 |
Formazione di John Jacobsen
| University of California, Berkeley | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- John Jacobsen
